Treace Medical Concepts logo
Treace Medical Concepts
TMCI | NASDAQ
Chart Builder DCF Calculator
$4.42
-$0.85 (-16.13%)
At close: Nov 16, 2026, 4:00 PM ET
$4.58
+$0.16 (+3.62%)
After-hours: Nov 16, 2026, 7:30 PM ET

Treace Medical Concepts Company Profile

Company profile explained

Company Profile

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Key Executives

Name Position
John T. Treace Founder, Chairman & Chief Executive Officer
Mark L. Hair Chief Financial Officer
Brad Barr Senior Vice President of Sales
Daniel E. Owens Chief Human Resources Officer
Scot Elder Chief Legal & Compliance Officer and Corporate Secretary
Sean F. Scanlan Chief Innovation & Marketing Officer
Shana Zink Senior Vice President of Clinical Affairs & Reimbursement
Taylor Erickson Chief Information & Cybersecurity Officer
Terry W. Lubben Chief Operations & Supply Chain Officer
Zac Potter Senior VP & Chief Accounting Officer

Latest SEC Filings

Date Type Title
Oct 28, 2026 4 Filing
Oct 02, 2026 4 Filing
Aug 24, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 4 Filing
Aug 12, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 4 Filing
Aug 12, 2026 4 Filing
Aug 07, 2026 10-Q Quarterly Report
Aug 07, 2026 8-K Current Report
View All SEC Filings ➞
Treace Medical Concepts
Treace Medical Concepts logo
Country United States
IPO Date Apr 23, 2021
Industry Medical - Devices
Sector Healthcare
Employees 450
CEO John T. Treace

Contact Details

100 Palmetto Park Place Ponte Vedra, Florida 32081 United States

Stock Details

Ticker Symbol TMCI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001630627
CUSIP Number 89455T109
ISIN Number US89455T1097
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.